Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2006 1
2008 1
2009 1
2010 2
2014 1
2015 1
2016 1
2018 3
2019 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Results by year
Filters applied: . Clear all
Page 1
The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade.
Schaer DA, Beckmann RP, Dempsey JA, Huber L, Forest A, Amaladas N, Li Y, Wang YC, Rasmussen ER, Chin D, Capen A, Carpenito C, Staschke KA, Chung LA, Litchfield LM, Merzoug FF, Gong X, Iversen PW, Buchanan S, de Dios A, Novosiadly RD, Kalos M. Schaer DA, et al. Among authors: staschke ka. Cell Rep. 2018 Mar 13;22(11):2978-2994. doi: 10.1016/j.celrep.2018.02.053. Cell Rep. 2018. PMID: 29539425 Free article.
Adapting to cell stress from inside and out.
Staschke KA, Wek RC. Staschke KA, et al. Nat Cell Biol. 2019 Jul;21(7):799-800. doi: 10.1038/s41556-019-0354-x. Nat Cell Biol. 2019. PMID: 31263267 No abstract available.
Effects of PERK eIF2α Kinase Inhibitor against Toxoplasma gondii.
Augusto L, Martynowicz J, Staschke KA, Wek RC, Sullivan WJ Jr. Augusto L, et al. Among authors: staschke ka. Antimicrob Agents Chemother. 2018 Oct 24;62(11):e01442-18. doi: 10.1128/AAC.01442-18. Print 2018 Nov. Antimicrob Agents Chemother. 2018. PMID: 30181373 Free PMC article.
HCV NS5A: A Multifunctional Regulator of Cellular Pathways and Virus Replication.
He Y, Staschke KA, Tan SL. He Y, et al. Among authors: staschke ka. In: Tan SL, editor. Hepatitis C Viruses: Genomes and Molecular Biology. Norfolk (UK): Horizon Bioscience; 2006. Chapter 9. In: Tan SL, editor. Hepatitis C Viruses: Genomes and Molecular Biology. Norfolk (UK): Horizon Bioscience; 2006. Chapter 9. PMID: 21250384 Free Books & Documents. Review.
How do tumours adapt to nutrient stress?
Wek RC, Staschke KA. Wek RC, et al. Among authors: staschke ka. EMBO J. 2010 Jun 16;29(12):1946-7. doi: 10.1038/emboj.2010.110. EMBO J. 2010. PMID: 20551969 Free PMC article. No abstract available.
Downregulation of PERK activity and eIF2α serine 51 phosphorylation by mTOR complex 1 elicits pro-oxidant and pro-death effects in tuberous sclerosis-deficient cells.
Krishnamoorthy J, Tenkerian C, Gupta J, Ghaddar N, Wang S, Darini C, Staschke KA, Ghosh A, Gandin V, Topisirovic I, Kristof AS, Hatzoglou M, Simos G, Koromilas AE. Krishnamoorthy J, et al. Among authors: staschke ka. Cell Death Dis. 2018 Feb 15;9(3):254. doi: 10.1038/s41419-018-0326-2. Cell Death Dis. 2018. PMID: 29449538 Free PMC article.
PERK Is a Haploinsufficient Tumor Suppressor: Gene Dose Determines Tumor-Suppressive Versus Tumor Promoting Properties of PERK in Melanoma.
Pytel D, Gao Y, Mackiewicz K, Katlinskaya YV, Staschke KA, Paredes MC, Yoshida A, Qie S, Zhang G, Chajewski OS, Wu L, Majsterek I, Herlyn M, Fuchs SY, Diehl JA. Pytel D, et al. Among authors: staschke ka. PLoS Genet. 2016 Dec 15;12(12):e1006518. doi: 10.1371/journal.pgen.1006518. eCollection 2016 Dec. PLoS Genet. 2016. PMID: 27977682 Free PMC article.
Identification of druggable cancer driver genes amplified across TCGA datasets.
Chen Y, McGee J, Chen X, Doman TN, Gong X, Zhang Y, Hamm N, Ma X, Higgs RE, Bhagwat SV, Buchanan S, Peng SB, Staschke KA, Yadav V, Yue Y, Kouros-Mehr H. Chen Y, et al. Among authors: staschke ka. PLoS One. 2014 May 29;9(5):e98293. doi: 10.1371/journal.pone.0098293. eCollection 2014. PLoS One. 2014. PMID: 24874471 Free PMC article.
14 results